Routine data collection and feedback at point-of-care improves most patient outcomes in hospice and palliative care.
Patients enrolled in hospice care had lower rates of healthcare utilization, and their costs for care were less during their last year of life.
A third of patients beginning palliative care die within a week.
Early Palliative Care Does Not Increase Costs in Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC)October 27, 2014
Palliative Care in Oncology Symposium: Palliative care for non-small cell lung cancer may not increase healthcare costs in the last 30 days of life.
Findings among older patients with terminal ovarian cancer receiving hospice care.
For Patients with Ovarian Cancer at End of Life, Paradoxical Increase in Use of Intensive Medical Services and HospiceOctober 16, 2014
Despite an increase in the use of hospice, the use of costly services for patients with ovarian cancer also increased.
Late admission more likely for younger patients, married men, hematologic malignancies.
Diarrhea is a treatment symptom as common as hair loss but with deadlier implications.
There is still more work to be done to ensure that palliative care is understood.
With the cost of cancer care rising, an ASCO task force has been established to create a framework for assessing relative value of cancer treatment.
New legislation aims to mandate action on an important aspect of cancer care.
Many patients believe that palliative chemo is curative treatment, so oncologists need to have important end-of-life discussions early in the course of cancer care.
Terminally ill cancer patients receiving chemotherapy at the end of life are at increased risk of dying in an ICU, according to a new study.
A hospital staff education intervention can improve several processes of palliative care in the inpatient setting.
About one-fifth of hospitalizations among patients with advanced gastrointestinal cancer are potentially avoidable.
Researchers see high response rate with first-in-class PDH inhibitor CPI-613.
The American Cancer Society is hosting live workshops about how patients' quality of life is improved when the palliative care conversation starts early.
New cancer therapies and statins demonstrate efficacy in treating and perhaps even preventing ovarian cancer recurrence.
Terminally ill patients who are well supported by religious communities use less hospice care and receive more aggressive medical interventions near death.
Do patients with incurable cancer have the right to decide when to end their own lives?
The topic of palliative care is no longer just an end-of-life discussion.
Varying definitions of the goals of hospice care and difficulty finding an appropriate program may confuse patients and their families.
Oncologists in a fee-for-service practice or paid a salary with productivity incentives were more likely to report their income would increase when they administer chemotherapy or growth factors than their salaried colleagues.
More research needed to understand impact of financial incentives on cost, quality of care.
Spiritual care—viewed by patients, nurses, and physicians as an important, appropriate, and beneficial component of end-of-life care—is infrequently provided by clinicians due primarily to lack of training, a study concluded in the Journal of Clinical Oncology online December 17.
In advanced cancer, parenteral hydration does not improve symptoms, QoL, or overall survival.
The proportion of US elderly patients dying of cancer who receive radiation therapy (RT) in the last month of life is low.
The American Thyroid Association's independent Anaplastic Thyroid Cancer Guidelines Taskforce published the first comprehensive guidelines for anaplastic thyroid cancer this month.
Early end-of-life discussions are associated with less aggressive care and greater use of hospice at the end of life.
Early Palliative Care Intervention Improves Satisfaction with Care, Prevents Decline in QOL in Patients with Metastatic DiseaseAugust 13, 2012
This CME activity from ASCO 2012 describes the benefits of early palliative care in patients with metastatic cancer.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Genetic Counseling Recommended for Advanced Prostate Cancer
- Higher-Dose Immunoglobulin Replacement Therapy in Chronic Lymphocytic Leukemia
- BRCA1/Shieldin Double Mutations May Signal Resistance to PARP Inhibitors
- "Impressive" CNS Responses With Osimertinib Compared With Standard EGFR-TKIs in Patients With CNS Metastases at Baseline
- Beyond BRCA: New Predisposition Genes Linked to Breast, Ovarian Cancers
- Higher Doses of Image-Guided Neoadjuvant Radiation Therapy Found to Be Safe in Locally Advanced NSCLC: Study
- Supply Shortages of Bacillus Calmette-Guérin Found to Spur Drug Rationing in Non-Muscle-Invasive Bladder Cancer
- Study Analyzing Postmarketing Data on Breast Implant Safety Sparks FDA Response
- Epacadostat and Pembrolizumab Combo Active in Relapsed NSCLC
- PD-1 Inhibitor Cemiplimab Shows Antitumor Activity in Relapsed NSCLC